Differences in Minimally Invasive Pancreatoduodenectomy Use and Outcomes
Author Information
Author(s): de Graaf Nine, Augustinus Simone, Wellner Ulrich F., Johansen Karin, Andersson Bodil, Beane Joal D., Björnsson Bergthor, Busch Olivier R., Davis Catherine H., Ghadimi Michael, Gleeson Elizabeth M., Groot Koerkamp Bas, Hogg Melissa E., van Santvoort Hjalmar C., Tingstedt Bobby, Uhl Waldemar, Werner Jens, Williamsson Caroline, Zeh Herbert J., Zureikat Amer H., Abu Hilal Mohammad, Pitt Henry A., Besselink Marc G.
Primary Institution: Amsterdam UMC, location University of Amsterdam, Amsterdam, the Netherlands
Hypothesis
The study aimed to investigate the use, patient selection, and outcomes of minimally invasive pancreatoduodenectomy (MIPD) compared to open pancreatoduodenectomy (OPD) across different countries.
Conclusion
The study found significant differences in the use and outcomes of MIPD and OPD among four transatlantic audits, highlighting the need for international collaboration to improve treatment standards.
Supporting Evidence
- 44,076 patients who underwent pancreatoduodenectomy were included in the analysis.
- MIPD use varied significantly among countries, with rates of 7% in North America, 4% in Germany, 17% in the Netherlands, and 0.1% in Sweden.
- Mortality rates did not differ significantly between MIPD and OPD across the audits.
- Patient factors predicting MIPD use included country, year of operation, performance status, and risk scores.
- Conversion rates were higher in laparoscopic MIPD compared to robotic MIPD.
Takeaway
This study looked at how different countries use a type of surgery called minimally invasive pancreatoduodenectomy and found that some countries do it more than others, and the results can be very different.
Methodology
A post hoc comparative analysis of registry data from four countries (North America, Germany, the Netherlands, and Sweden) from 2014 to 2020.
Potential Biases
Potential bias due to the voluntary nature of data collection in some countries, leading to a disproportionate representation of higher-volume centers.
Limitations
The study faced selection and registration bias due to non-mandatory participation in some audits and differences in variable definitions.
Participant Demographics
The median age of participants was 67 years, with 46% being female; the majority had pancreatic ductal adenocarcinoma.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website